Skip to main content
TipRanks
Go Ultimate75% OFF
Modulight Biotherapeutics logo

Modulight Biotherapeutics: Valuation, Funding & Investors

501 Boylston St Boston, Massachusetts 02116, UShttps://www.modulight.bio/Therapeutics

Modulight Biotherapeutics is a developer of a novel optogenetic platform for the treatment of neurological disorders. The company focuses on advancing its therapeutic product pipeline towards clinical applications.

Leadership & Board

Current Number of Employees
23
Current LinkedIn Followers
1,569

Latest Estimated Valuation

Total Amount Raised
$12M
Total Funding Rounds
1
Latest Funding Amount
$12M
Latest Funding Round
Seed Round

Employee Trend

Modulight Biotherapeutics had 23 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

23Latest Employee Count
0(0.00%)Week-Over-Week Change
010203040Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

Modulight Biotherapeutics had 1,569 followers as of November 16, 2026. The number of followers increased by 8 (0.51%) week-over-week.

1,569Latest Followers Count
8(0.51%)Week-Over-Week Change
05001,0001,5002,000Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Nov 12, 2025Seed Round$12.20M―

Investors

Investor NameFunding Round
Nexus NeuroTech VenturesSeed Round
Jibe VenturesSeed Round
LocalGlobeSeed Round
Redseed VCSeed Round
Secret Chord VenturesSeed Round
Fresh FundSeed Round
Saras CapitalSeed Round
SilverArc CapitalSeed Round

Similar Companies

A snapshot of private companies similar to Modulight Biotherapeutics, helping you discover and navigate related company profiles.

Related News and Analysis